HomeENZN • OTCMKTS
add
Enzon Pharmaceuticals Inc
Previous close
$0.11
Day range
$0.11 - $0.12
Year range
$0.060 - $0.24
Market cap
9.21M USD
Avg Volume
107.00K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 325.00K | 50.46% |
Net income | -72.00K | -110.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | 132.58% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.86M | -0.33% |
Total assets | 47.17M | -1.12% |
Total liabilities | 1.68M | -2.10% |
Total equity | 45.49M | — |
Shares outstanding | 74.21M | — |
Price to book | 2.75 | — |
Return on assets | -1.72% | — |
Return on capital | -1.76% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -72.00K | -110.71% |
Cash from operations | 226.00K | -50.33% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | 226.00K | -50.33% |
Free cash flow | 1.08M | -7.70% |
About
Enzon Pharmaceuticals, Inc. is a pharmaceutical company. Its headquarters is in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the symbol "ENZN". It's also doing marketing works in Asia areas such as China. In 2012, the company orally presented in Nanjing, China about the symposium of its drug delivery systems, which help improve therapeutic molecules' pharmaceutical properties. Wikipedia
Founded
1981
Headquarters
Website
